X0306 4 2019-11-04 0 0001720725 Oyster Point Pharma, Inc. OYST 0001687880 Versant Venture Capital VI, L.P. ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001777654 Versant Ventures VI GP, L.P. ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001777652 Versant Ventures VI GP-GP, LLC ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001765253 Versant Vantage I, L.P. ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001777651 Versant Vantage I GP, L.P. ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001777653 Versant Vantage I GP-GP, LLC ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001456589 Versant Ventures IV, LLC ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001456590 Versant Venture Capital IV, L.P. ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001456591 Versant Side Fund IV, L.P. ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 Common Stock, par value $0.001 per share 2019-11-04 4 C 0 10420 A 12438 I See footnotes Common Stock, par value $0.001 per share 2019-11-04 4 C 0 1654359 A 1974798 I See footnotes Common Stock, par value $0.001 per share 2019-11-04 4 P 0 27500 16.00 A 2002298 I See footnotes Common Stock, par value $0.001 per share 2019-11-04 4 C 0 1941500 A 1941500 D Common Stock, par value $0.001 per share 2019-11-04 4 C 0 495388 A 2436888 D Common Stock, par value $0.001 per share 2019-11-04 4 P 0 125000 16.00 A 2561888 D Common Stock, par value $0.001 per share 2019-11-04 4 C 0 566158 A 566158 I See footnote Common Stock, par value $0.001 per share 2019-11-04 4 P 0 437500 16.00 A 1003658 I See footnote Series A Convertible Preferred Stock 2019-11-04 4 C 0 10420 D Common Stock, par value $0.001 per share 10420 0 I See footnotes Series A Convertible Preferred Stock 2019-11-04 4 C 0 1654359 D Common Stock, par value $0.001 per share 1654359 0 I See footnotes Series A Convertible Preferred Stock 2019-11-04 4 C 0 1941500 D Common Stock, par value $0.001 per share 1941500 0 D Series B Convertible Preferred Stock 2019-11-04 4 C 0 495388 D Common Stock, par value $0.001 per share 495388 0 D Series B Convertible Preferred Stock 2019-11-04 4 C 0 566158 D Common Stock, par value $0.001 per share 566158 0 I See footnote These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Common Stock ("Shares"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date. Shares held by Versant Side Fund IV, L.P. ("Versant Side Fund IV"). Shares held by Versant Venture Capital IV, L.P. ("Versant IV"). Versant Ventures IV, LLC ("Versant Ventures IV") is the sole general partner of each of Versant IV and Versant Side Fund IV. Each of Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, Kirk G. Nielsen, Thomas F. Woiwode and Robin L. Praeger, as managing members of Versant Ventures IV, may be deemed to share voting and dispositive power over the shares held by Versant IV and Versant Side Fund IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports. Shares directly held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Each of Bradley J. Bolzon, Jerel C. Davis, Kirk G. Nielsen, Robin L. Praeger and Thomas F. Woiwode, and as November 1, 2019 Clare Ozawa, as managing members of Versant Ventures VI GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant VI; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Shares held by Versant Vantage I, L.P. ("Versant Vantage"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Each of Bradley J. Bolzon, Jerel C. Davis, Clare Ozawa, Robin L. Praeger and Thomas F. Woiwode, as managing members of Versant Vantage I GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant Vantage; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly, files separate Section 16 reports. /s/ Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P Its: General Partner By: Versant Ventures VI GP-GP, LLC By: Robin L. Praeger Its: Manager 2019-11-04 /s/ Versant Ventures VI GP, L.P. By: Versant Ventures VI GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Manager 2019-11-04 /s/ Versant Ventures VI GP-GP, LLC By: Robin L. Praeger Its: Manager 2019-11-04 /s/ Versant Vantage I, L.P. By: Versant Vantage I GP, L.P. Its: General Partner By: Versant Vantage I GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Manager 2019-11-04 /s/ Versant Vantage I GP, L.P. By: Versant Vantage I GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Manager 2019-11-04 /s/ Versant Vantage I GP-GP, LLC By: Robin L. Praeger Its: Manager 2019-11-04 /s/ Versant Ventures IV, LLC By: Robin L. Praeger Its: Manager 2019-11-04 /s/ Versant Venture Capital IV, L.P. By: Versant Ventures IV, LLC Its: General Partner By: Robin L. Praeger Its: Manager 2019-11-04 /s/ Versant Side Fund IV, L.P. By: Versant Ventures IV, LLC Its: General Partner By: Robin L. Praeger Its: Manager 2019-11-04